On the basis of these data it is reasonable to assume that if the transgenic mouse model PSA-Luc were crossed with transgenic models that develop prostate cancer it would be possible to visulalize the onset, growth and progression of prostate cancer through BLI. The gene discussed is KLK3; the disease is prostate carcinoma.